alexa Evaluation of the direct and indirect response of blood leukocytes to carbon nanotubes (CNTs).
Materials Science

Materials Science

Journal of Nanomedicine & Biotherapeutic Discovery

Author(s): Medepalli K, Alphenaar B, Raj A, Sethu P, Medepalli K, Alphenaar B, Raj A, Sethu P, Medepalli K, Alphenaar B, Raj A, Sethu P, Medepalli K, Alphenaar B, Raj A, Sethu P

Abstract Share this page

Abstract Carbon nanotubes (CNTs) possess unique structural and functional properties and are readily internalized by various mammalian cells, making them highly attractive as a tool for gene and drug delivery. However, prior to use in vivo as carriers for therapeutics, their toxicity and potential to elicit an immune response need to be understood. To evaluate the acute response of blood leukocytes to CNTs in vitro, we recreated two specific events: (a) a direct-exposure event that may occur due to presence of CNTs in circulation and (b) presentation of CNTs to blood leukocytes via antigen presenting cells. The potential for activation of different leukocyte subpopulations was then evaluated by profiling various early activation markers using flow cytometry. To ensure relevance to gene and drug delivery, these experiments utilized single-walled CNTs (SWCNTs) functionalized with single-stranded (ss)-DNA fragments consisting of guanine-thymine (GT) repeat sequences, which have potential to serve as a backbone for transport of biomolecules and also as a surfactant to prevent aggregation. Results from this study demonstrate that ssDNA-functionalized SWCNTs does not elicit an acute immune response from blood leukocytes through either direct or indirect interactions as verified by the expression of early leukocyte activation markers. FROM THE CLINICAL EDITOR: Carbon nanotubes offer a possible option for targeted gene and drug delivery, but first their toxicity and potential to elicit an immune response need to be understood. The authors of this study demonstrate that ssDNA-functionalized SWCNTs do not elicit an acute immune response from blood leukocytes as verified by the expression of early leukocyte activation markers. Copyright © 2011 Elsevier Inc. All rights reserved. This article was published in Nanomedicine and referenced in Journal of Nanomedicine & Biotherapeutic Discovery

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords